Follow the people · Insider
Mark Sullivan
Mark Sullivan files insider transactions with the SEC as a chief legal officer of Definium Therapeutics (DFTX). We hold 2 disclosed purchases and sales filed since 11 July 2011, 1 of them in the last 90 days.
- Files forDFTX
- Disclosed buys and sells2 in all, 1 in the last 90 days
- Last disclosure12 August 2026
Positions held
4 posts we hold — a term names its own dates; a run of filings only says when they filed- Filed 3 February 2026 — 12 August 2026Chief Legal Officer · Definium Therapeutics (DFTX)7 Form 4 lines · source: SEC Form 4
- Filed 13 April 2023 — 26 December 2025Chief Legal Officer · Mind Medicine (MindMed) (MNMD)10 Form 4 lines · source: SEC Form 4
- Filed 1 August 2019 — 2 March 2023General Counsel & Secretary · Sesen Bio (SESN)10 Form 4 lines · source: SEC Form 4
- Filed 11 July 2011 — 14 December 2011Gen Counsel, CCO & Secretary · MedQuist Holdings (MEDH)8 Form 4 lines · source: SEC Form 4
Everything they disclosed
35 entries, newest first — one per disclosure report, one per Form 4 line- was granted 62,500 shares of Definium TherapeuticsSEC Form 412 August 2026Common Shares · traded 12 August 2026 · filed 12 August 2026
- ▼ sold on the open market 13,008 shares of Definium TherapeuticsSEC Form 426 June 2026Common Shares · traded 25 June 2026 · filed 26 June 2026
- was granted 62,500 shares of Definium TherapeuticsSEC Form 422 June 2026Common Shares · traded 22 June 2026 · filed 22 June 2026
- ▼ sold on the open market 10,702 shares of Definium TherapeuticsSEC Form 426 March 2026Common Shares · traded 25 March 2026 · filed 26 March 2026
- ▼ sold on the open market 10,702 shares of Definium TherapeuticsSEC Form 426 March 2026Common Shares · traded 25 March 2026 · filed 26 March 2026
- was granted 125,000 shares of Definium TherapeuticsSEC Form 45 February 2026Common Shares · traded 3 February 2026 · filed 5 February 2026
- was granted 125,000 shares of Definium TherapeuticsSEC Form 45 February 2026Common Shares · traded 3 February 2026 · filed 5 February 2026
- ▼ sold on the open market 11,276 shares of Mind Medicine (MindMed)SEC Form 429 December 2025Common Shares · traded 26 December 2025 · filed 29 December 2025
- ▼ sold on the open market 11,278 shares of Mind Medicine (MindMed)SEC Form 426 September 2025Common Shares · traded 25 September 2025 · filed 26 September 2025
- ▼ sold on the open market 11,491 shares of Mind Medicine (MindMed)SEC Form 426 June 2025Common Shares · traded 25 June 2025 · filed 26 June 2025
- ▼ sold on the open market 6,576 shares of Mind Medicine (MindMed)SEC Form 426 March 2025Common Shares · traded 25 March 2025 · filed 26 March 2025
- was granted 150,000 shares of Mind Medicine (MindMed)SEC Form 413 March 2025Common Shares · traded 12 March 2025 · filed 13 March 2025
- ▼ sold on the open market 4,519 shares of Mind Medicine (MindMed)SEC Form 427 December 2024Common Shares · traded 26 December 2024 · filed 27 December 2024
- ▼ sold on the open market 4,430 shares of Mind Medicine (MindMed)SEC Form 425 September 2024Common Shares · traded 25 September 2024 · filed 25 September 2024
- ▼ sold on the open market 17,854 shares of Mind Medicine (MindMed)SEC Form 425 June 2024Common Shares · traded 25 June 2024 · filed 25 June 2024
- was granted 125,000 shares of Mind Medicine (MindMed) (a derivative holding)SEC Form 429 February 2024Stock Option (Right to Buy) · traded 27 February 2024 · filed 29 February 2024
- was granted 200,000 shares of Mind Medicine (MindMed)SEC Form 414 April 2023Common Shares · traded 13 April 2023 · filed 14 April 2023
- ▼ sold on the open market 100,978 shares of Sesen BioSEC Form 46 March 2023Common Stock · traded 2 March 2023 · filed 6 March 2023
- exercised options over 185,000 shares of Sesen BioSEC Form 46 March 2023Common Stock · traded 2 March 2023 · filed 6 March 2023
- ▼ sold on the open market 73,361 shares of Sesen BioSEC Form 46 March 2023Common Stock · traded 2 March 2023 · filed 6 March 2023
- exercised options over 113,175 shares of Sesen BioSEC Form 46 March 2023Common Stock · traded 2 March 2023 · filed 6 March 2023
- ▼ sold on the open market 44,879 shares of Sesen BioSEC Form 46 March 2023Common Stock · traded 2 March 2023 · filed 6 March 2023
- ▼ sold on the open market 39,831 shares of Sesen BioSEC Form 423 February 2023Common Stock · traded 21 February 2023 · filed 23 February 2023
- was granted 339,525 shares of Sesen BioSEC Form 423 February 2022Common Stock · traded 18 February 2022 · filed 23 February 2022
- was granted 300,000 shares of Sesen Bio (a derivative holding)SEC Form 423 February 2021Employee Stock Option (Right to Buy) · traded 19 February 2021 · filed 23 February 2021
- was granted 260,000 shares of Sesen Bio (a derivative holding)SEC Form 418 February 2020Employee Stock Option (Right to Buy) · traded 13 February 2020 · filed 18 February 2020
- was granted 200,000 shares of Sesen Bio (a derivative holding)SEC Form 45 August 2019Employee Stock Option (Right to Buy) · traded 1 August 2019 · filed 5 August 2019
- ▼ sold on the open market 1,272 shares of MedQuist HoldingsSEC Form 44 January 2012Common Stock · traded 13 December 2011 · filed 4 January 2012
- ▼ sold on the open market 2,447 shares of MedQuist HoldingsSEC Form 44 January 2012Common Stock · traded 14 December 2011 · filed 4 January 2012
- ▼ sold on the open market 1,000 shares of MedQuist HoldingsSEC Form 44 January 2012Common Stock · traded 14 December 2011 · filed 4 January 2012
- had shares withheld for tax on 1,226 shares of MedQuist HoldingsSEC Form 44 January 2012Common Stock · traded 30 September 2011 · filed 4 January 2012
- had shares withheld for tax on 1,247 shares of MedQuist HoldingsSEC Form 415 December 2011Common Stock · traded 11 July 2011 · filed 15 December 2011
- had shares withheld for tax on 1,205 shares of MedQuist HoldingsSEC Form 415 December 2011Common Stock · traded 30 September 2011 · filed 15 December 2011
- was granted 42,992 shares of MedQuist HoldingsSEC Form 413 July 2011Common Stock · traded 11 July 2011 · filed 13 July 2011
- was granted 2,500 shares of MedQuist Holdings (a derivative holding)SEC Form 411 July 2011Stock Option (right to buy) · traded 11 July 2011 · filed 11 July 2011
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.